US Stock MarketDetailed Quotes
ALLT Allot
- 4.570
- +0.340+8.04%
Close Nov 25 16:00 ET
- 4.490
- -0.080-1.75%
Post 20:01 ET
179.55MMarket Cap-7030P/E (TTM)
4.640High4.410Low853.31KVolume4.560Open4.230Pre Close3.90MTurnover3.19%Turnover RatioLossP/E (Static)39.29MShares4.64052wk High3.75P/B122.36MFloat Cap1.19052wk Low--Dividend TTM26.78MShs Float29.050Historical High--Div YieldTTM5.44%Amplitude1.190Historical Low4.570Avg Price1Lot Size
Allot Stock Forum
Sign in to post a comment
10
1
$Allot (ALLT.US)$
Positive
First non-GAAP operating profit ($1.1M) in three years
SECaaS revenues grew 69% YoY to $4.7M
Revenue increased 5% sequentially and 3% YoY to $23.2M
Non-GAAP gross margin improved to 71.7%
Generated positive operating cash flow of $1.9M
Net cash increased by $2.0M vs previous quarter
Negative
GAAP operating loss of $0.2M
GAAP net loss of $0.2M ($0.01 per share)
Positive
First non-GAAP operating profit ($1.1M) in three years
SECaaS revenues grew 69% YoY to $4.7M
Revenue increased 5% sequentially and 3% YoY to $23.2M
Non-GAAP gross margin improved to 71.7%
Generated positive operating cash flow of $1.9M
Net cash increased by $2.0M vs previous quarter
Negative
GAAP operating loss of $0.2M
GAAP net loss of $0.2M ($0.01 per share)
Shareholders of Allot may be disgruntled due to the firm's poor recent performance and excessive CEO compensation. A review of executive pay could be on cards considering the sharp drop in EPS and investor loss over the past three years.
The stock's low P/S ratio, likely due to investors' doubt on robust revenue growth prospects and current conditions like declining revenues, could keep the share price low unless top-line growth substantially improves.
Top 4 why only 4? Because those are all that are buying
$Allot (ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies (SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology (PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics (AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.
$Allot (ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies (SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology (PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics (AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.
4
10
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
BREEZUSCHRIST : Where Did u find this chart